4:08 PM ET
8-K
Investor Presentation
Perspective Therapeutics Investor Presentation
Perspective Therapeutics updated its corporate presentation detailing its pipeline of next-generation radiopharmaceuticals, including clinical-stage programs VMT-α-NET, VMT01, and PSV359. The presentation highlights clinical data for its lead programs in neuroendocrine tumors and melanoma, as well as its integrated isotope production and manufacturing strategy.